Skip to main content
BSE - SMEListed
Clinitech Laboratory Limited Logo

Clinitech Laboratory Limited IPO

Clinitech Laboratory Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 115.00 (+19.79%)

Clinitech Laboratory Limited's completed its IPO journey with a successful listing on BSE on 01-08-2024. The public offering mobilized 6,02,400 Shares in total capital, comprising 6,02,400 Shares in fresh equity.

The offering was conducted within the price band of ₹96 to ₹96, with minimum application lots of 1200 shares. Investor participation during the 25-07-2024 to 29-07-2024 subscription window determined the final allocation pattern.

The basis of allotment was announced on 30-07-2024, finalizing share distribution to successful applicants. The listing represents a significant corporate development, providing the company with enhanced visibility and access to public capital markets.

Clinitech Laboratory IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Clinitech Laboratory IPO Key Performance Indicator
Company Financials ( In Lakhs )

Clinitech Laboratory IPO About Company

Clinitech Laboratory Limited, established in 1990, runs 8 diagnostic centers across Thane and Navi Mumbai, offering a wide range of healthcare and diagnostic tests. The company conducts over 3 lakh tests annually in its NABL-accredited labs (National Accreditation Board for Testing and Calibration Laboratories), equipped with advanced technology and high-end equipment. Its Airoli, Navi Mumbai facility holds an ISO 15189:2012 accreditation certificate for quality testing services. As of December 31, 2023, Clinitech has a team of 74 employees dedicated to delivering accurate and reliable healthcare services.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Clinitech Laboratory IPO Strength Factors

  1. NABL Accreditation: Clinitech Laboratory Limited's labs are approved by NABL, guaranteeing accurate and reliable diagnostic services.
  2. Diagnostic Centers Network: The company runs 8 modern diagnostic centers across Thane and Navi Mumbai, providing a wide range of healthcare services.
  3. Expert Leadership: Led by experienced promoters and management, the company has built a strong reputation with proven success in the healthcare industry.

Clinitech Laboratory IPO Risk Factors

  1. Brand Maintenance: If Clinitech Laboratory Limited doesn't maintain and grow its brand name and image, it could hurt the company's business and future opportunities.
  2. Quality Standards: If the company fails to consistently deliver high-quality services, it could negatively affect its business performance and financial health.
  3. Geographic Concentration: Since most of the company's operations are based in Thane and Navi Mumbai, any disruptions in these regions could impact its business and financial stability.

Clinitech Laboratory IPO Lead Manager(s)

  • Inventure Merchant Banker Services Private Limited

Clinitech Laboratory IPO Promoter(s)

  1. Jagdish Umakant Nayak
  2. Jyoti Jagdish Nayak

Clinitech Laboratory IPO Company Details

Clinitech Laboratory Limited
Phone:
address:

Clinitech Laboratory IPO Registrar

Bigshare Services Private Limited
Name:
Phone:

Clinitech Laboratory IPO FAQs